FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2156888164> ?p ?o ?g. }

• W2156888164 endingPage "881" @default.
• W2156888164 startingPage "871" @default.
• W2156888164 abstract "Uncontrolled hepatic glucose output (HGO) contributes significantly to the pathological hyperglycemic state of patients with type 2 diabetes. Glucagon, through action on its receptor, stimulates HGO, thereby leading to increased glycemia. Antagonizing the glucagon signaling pathway represents an attractive therapeutic approach for the treatment of type 2 diabetes. We previously reported the generation and characterization of several high-affinity monoclonal antibodies (mAbs) targeting the glucagon receptor (GCGR). In the present study, we demonstrate that a 5-week treatment of diet-induced obese mice with mAb effectively normalized nonfasting blood glucose. Similar treatment also reduced fasting blood glucose without inducing hypoglycemia or other undesirable metabolic perturbations. In addition, no hypoglycemia was found in <i>db/db</i> mice that were treated with a combination of insulin and mAb. Long-term treatment with the mAb caused dose-dependent hyperglucagonemia and minimal to mild α-cell hyperplasia in lean mice. There was no evidence of pancreatic α-cell neoplastic transformation in mice treated with mAb for as long as 18 weeks. Treatment-induced hyperglucagonemia and α-cell hyperplasia were reversible after treatment withdrawal for periods of 4 and 10 weeks, respectively. It is noteworthy that pancreatic β-cell function was preserved, as demonstrated by improved glucose tolerance throughout the 18-week treatment period. Our studies further support the concept that long-term inhibition of GCGR signaling by a mAb could be an effective approach for controlling diabetic hyperglycemia." @default.
• W2156888164 created "2016-06-24" @default.
• W2156888164 creator A5006085236 @default.
• W2156888164 creator A5010252578 @default.
• W2156888164 creator A5012830823 @default.
• W2156888164 creator A5014551530 @default.
• W2156888164 creator A5015664805 @default.
• W2156888164 creator A5028300743 @default.
• W2156888164 creator A5030820200 @default.
• W2156888164 creator A5034552923 @default.
• W2156888164 creator A5036630106 @default.
• W2156888164 creator A5063599208 @default.
• W2156888164 creator A5069757286 @default.
• W2156888164 creator A5071754938 @default.
• W2156888164 creator A5076676311 @default.
• W2156888164 creator A5083903008 @default.
• W2156888164 creator A5084427684 @default.
• W2156888164 date "2009-08-31" @default.
• W2156888164 modified "2023-10-16" @default.
• W2156888164 title "Long-Term Inhibition of the Glucagon Receptor with a Monoclonal Antibody in Mice Causes Sustained Improvement in Glycemic Control, with Reversible α-Cell Hyperplasia and Hyperglucagonemia" @default.
• W2156888164 cites W1572048900 @default.
• W2156888164 cites W1572257893 @default.
• W2156888164 cites W1988784323 @default.
• W2156888164 cites W2001123985 @default.
• W2156888164 cites W2001226324 @default.
• W2156888164 cites W2009237205 @default.
• W2156888164 cites W2012446425 @default.
• W2156888164 cites W2019465783 @default.
• W2156888164 cites W2036141586 @default.
• W2156888164 cites W2046912474 @default.
• W2156888164 cites W2073625634 @default.
• W2156888164 cites W2074528335 @default.
• W2156888164 cites W2088987697 @default.
• W2156888164 cites W2092700428 @default.
• W2156888164 cites W2093559498 @default.
• W2156888164 cites W2113126709 @default.
• W2156888164 cites W2113544353 @default.
• W2156888164 cites W2116862105 @default.
• W2156888164 cites W2118479946 @default.
• W2156888164 cites W2123798977 @default.
• W2156888164 cites W2127167047 @default.
• W2156888164 cites W2129983555 @default.
• W2156888164 cites W2152578678 @default.
• W2156888164 cites W2166745957 @default.
• W2156888164 cites W2168726045 @default.
• W2156888164 cites W2330273698 @default.
• W2156888164 cites W4206185892 @default.
• W2156888164 cites W4239319427 @default.
• W2156888164 cites W4246094108 @default.
• W2156888164 cites W4247555495 @default.
• W2156888164 doi "https://doi.org/10.1124/jpet.109.157685" @default.
• W2156888164 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19720878" @default.
• W2156888164 hasPublicationYear "2009" @default.
• W2156888164 type Work @default.
• W2156888164 sameAs 2156888164 @default.
• W2156888164 citedByCount "93" @default.
• W2156888164 countsByYear W21568881642012 @default.
• W2156888164 countsByYear W21568881642013 @default.
• W2156888164 countsByYear W21568881642014 @default.
• W2156888164 countsByYear W21568881642015 @default.
• W2156888164 countsByYear W21568881642016 @default.
• W2156888164 countsByYear W21568881642017 @default.
• W2156888164 countsByYear W21568881642018 @default.
• W2156888164 countsByYear W21568881642019 @default.
• W2156888164 countsByYear W21568881642020 @default.
• W2156888164 countsByYear W21568881642021 @default.
• W2156888164 countsByYear W21568881642022 @default.
• W2156888164 crossrefType "journal-article" @default.
• W2156888164 hasAuthorship W2156888164A5006085236 @default.
• W2156888164 hasAuthorship W2156888164A5010252578 @default.
• W2156888164 hasAuthorship W2156888164A5012830823 @default.
• W2156888164 hasAuthorship W2156888164A5014551530 @default.
• W2156888164 hasAuthorship W2156888164A5015664805 @default.
• W2156888164 hasAuthorship W2156888164A5028300743 @default.
• W2156888164 hasAuthorship W2156888164A5030820200 @default.
• W2156888164 hasAuthorship W2156888164A5034552923 @default.
• W2156888164 hasAuthorship W2156888164A5036630106 @default.
• W2156888164 hasAuthorship W2156888164A5063599208 @default.
• W2156888164 hasAuthorship W2156888164A5069757286 @default.
• W2156888164 hasAuthorship W2156888164A5071754938 @default.
• W2156888164 hasAuthorship W2156888164A5076676311 @default.
• W2156888164 hasAuthorship W2156888164A5083903008 @default.
• W2156888164 hasAuthorship W2156888164A5084427684 @default.
• W2156888164 hasConcept C126322002 @default.
• W2156888164 hasConcept C134018914 @default.
• W2156888164 hasConcept C159654299 @default.
• W2156888164 hasConcept C170493617 @default.
• W2156888164 hasConcept C185280430 @default.
• W2156888164 hasConcept C203014093 @default.
• W2156888164 hasConcept C2777562237 @default.
• W2156888164 hasConcept C2778542361 @default.
• W2156888164 hasConcept C2778563252 @default.
• W2156888164 hasConcept C2778938600 @default.
• W2156888164 hasConcept C2779306644 @default.
• W2156888164 hasConcept C2780668416 @default.
• W2156888164 hasConcept C2908748658 @default.
• W2156888164 hasConcept C542903549 @default.
• W2156888164 hasConcept C71924100 @default.

• next